Education
About Us
Working with TipRanks
Follow Us
Legend Biotech Corporation (LEGN)
NASDAQ:LEGN
LEGN Analyst Ratings
Strong Buy
14 Buy
1 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
LEGN Stock 12 Month Forecast
Average Price Target
$78.82
▲(135.78%Upside)
| Highest Price Target$94.00 | Average Price Target$78.82 | Lowest Price Target$55.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
TipRanks
$35
Hold
4.70%
Upside
Reiterated
06/21/25
The overall stock score of 55 is driven primarily by strong earnings call outcomes and positive technical indicators. However, significant challenges in financial performance, particularly in profitability and cash flow, and an unattractive valuation profile temper the overall score. The company's strategic efforts and market position in the CAR-T space provide a positive long-term outlook, but short-term financial hurdles remain.
RBC Capital
$78
Buy
133.32%
Upside
Reiterated
06/26/25
BMO Capital
$90
Buy
169.22%
Upside
Reiterated
06/23/25
Raymond James
$37.91→$86
Buy
157.25%
Upside
Reiterated
06/13/25
Barclays
$94
Buy
181.18%
Upside
Reiterated
06/03/25
J.P. Morgan
―
Buy
―
Reiterated
06/02/25
Scotiabank
$76
Buy
127.34%
Upside
Reiterated
06/02/25
BTIG
$91
Buy
172.21%
Upside
Reiterated
05/23/25
Piper Sandler
$78
Buy
133.32%
Upside
Reiterated
05/23/25
Truist Financial
$88→$71
Buy
112.38%
Upside
Reiterated
05/14/25
H.C. Wainwright
$75
Buy
124.35%
Upside
Reiterated
05/14/25
TD Cowen
$62
Buy
85.46%
Upside
Reiterated
05/13/25
William Blair
―
Hold
―
Reiterated
05/13/25
Jefferies
$91
Buy
172.21%
Upside
Reiterated
05/13/25
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
TipRanks
$35
Hold
4.70%
Upside
Reiterated
06/21/25
The overall stock score of 55 is driven primarily by strong earnings call outcomes and positive technical indicators. However, significant challenges in financial performance, particularly in profitability and cash flow, and an unattractive valuation profile temper the overall score. The company's strategic efforts and market position in the CAR-T space provide a positive long-term outlook, but short-term financial hurdles remain.
RBC Capital
$78
Buy
133.32%
Upside
Reiterated
06/26/25
BMO Capital
$90
Buy
169.22%
Upside
Reiterated
06/23/25
Raymond James
$37.91→$86
Buy
157.25%
Upside
Reiterated
06/13/25
Barclays
$94
Buy
181.18%
Upside
Reiterated
06/03/25
J.P. Morgan
―
Buy
―
Reiterated
06/02/25
Scotiabank
$76
Buy
127.34%
Upside
Reiterated
06/02/25
BTIG
$91
Buy
172.21%
Upside
Reiterated
05/23/25
Piper Sandler
$78
Buy
133.32%
Upside
Reiterated
05/23/25
Truist Financial
$88→$71
Buy
112.38%
Upside
Reiterated
05/14/25
H.C. Wainwright
$75
Buy
124.35%
Upside
Reiterated
05/14/25
TD Cowen
$62
Buy
85.46%
Upside
Reiterated
05/13/25
William Blair
―
Hold
―
Reiterated
05/13/25
Jefferies
$91
Buy
172.21%
Upside
Reiterated
05/13/25
Best Analysts Covering Legend Biotech
1 Month
xxx
Success Rate
9/15 ratings generated profit
Average Return
+2.21%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 60.00% of your transactions generating a profit, with an average return of +2.21% per trade.
3 Months
xxx
Success Rate
7/15 ratings generated profit
Average Return
+2.61%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 46.67% of your transactions generating a profit, with an average return of +2.61% per trade.
1 Year
Success Rate
8/15 ratings generated profit
Average Return
-5.41%
reiterated a buy rating last month
Copying Edward Tenthoff's trades and holding each position for 1 Year would result in 53.33% of your transactions generating a profit, with an average return of -5.41% per trade.
2 Years
xxx
Success Rate
5/15 ratings generated profit
Average Return
-11.28%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 33.33% of your transactions generating a profit, with an average return of -11.28% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
LEGN Analyst Recommendation Trends
Rating
Feb 25
Mar 25
Apr 25
May 25
Jun 25
Strong Buy
20
22
24
35
32
Buy
0
1
1
1
1
Hold
1
2
2
5
3
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
21
25
27
41
36
Each month's total comprises the sum of three months' worth of ratings.
LEGN Financial Forecast
LEGN Stock Forecast FAQ
What is LEGN’s average 12-month price target, according to analysts?
Based on analyst ratings, Legend Biotech Corporation’s 12-month average price target is 78.82.
What is LEGN’s upside potential, based on the analysts’ average price target?
Legend Biotech Corporation has 135.78% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is LEGN a Buy, Sell or Hold?
Legend Biotech Corporation has a consensus rating of Strong Buy which is based on 14 buy ratings, 1 hold ratings and 0 sell ratings.
What is Legend Biotech Corporation’s price target?
The average price target for Legend Biotech Corporation is 78.82. This is based on 15 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $94.00 ,the lowest forecast is $55.00. The average price target represents 135.78% Increase from the current price of $33.43.
The highest analyst price target is $94.00 ,the lowest forecast is $55.00. The average price target represents 135.78% Increase from the current price of $33.43.
What do analysts say about Legend Biotech Corporation?
Legend Biotech Corporation’s analyst rating consensus is a Strong Buy. This is based on the ratings of 15 Wall Streets Analysts.
How can I buy shares of LEGN?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.